 | • レポートコード：QAF27633 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のCRISPR＆CRISPR関連（Cas）遺伝子市場について種類別（ゲノム編集、遺伝子、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株）、用途別（バイオテクノロジー企業、製薬企業、学術機関、研究開発機関）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・CRISPR＆CRISPR関連（Cas）遺伝子市場の概要 ・世界の主要地域別CRISPR＆CRISPR関連（Cas）遺伝子市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のCRISPR＆CRISPR関連（Cas）遺伝子市場規模2016-2021：種類別（ゲノム編集、遺伝子、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株） ・世界のCRISPR＆CRISPR関連（Cas）遺伝子市場予測2012-2027：種類別（ゲノム編集、遺伝子、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株） ・世界のCRISPR＆CRISPR関連（Cas）遺伝子市場規模2016-2021：用途別（バイオテクノロジー企業、製薬企業、学術機関、研究開発機関） ・世界のCRISPR＆CRISPR関連（Cas）遺伝子市場予測2012-2027：用途別（バイオテクノロジー企業、製薬企業、学術機関、研究開発機関） ・CRISPR＆CRISPR関連（Cas）遺伝子のアメリカ市場規模と予測2016-2021 ・CRISPR＆CRISPR関連（Cas）遺伝子のヨーロッパ市場規模と予測2016-2021 ・CRISPR＆CRISPR関連（Cas）遺伝子の中国市場規模と予測2016-2021 ・CRISPR＆CRISPR関連（Cas）遺伝子の日本市場規模と予測2016-2021 ・CRISPR＆CRISPR関連（Cas）遺伝子の東南アジア市場規模と予測2016-2021 ・CRISPR＆CRISPR関連（Cas）遺伝子のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Caribou Biosciences、Addgene、CRISPR THERAPEUTICS、Merck KGaA、Mirus Bio LLC、Editas Medicine、Takara Bio USA、Thermo Fisher Scientific、Horizon Discovery Group、Intellia Therapeutics、GE Healthcare Dharmacon） ・CRISPR＆CRISPR関連（Cas）遺伝子の製造コスト分析 ・販売チャネル、流通業者、顧客 ・CRISPR＆CRISPR関連（Cas）遺伝子の市場動向・機会・課題 ・調査の結論 |
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of “spacer DNA” from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Market Analysis and Insights: Global CRISPR and CRISPR-Associated (Cas) Genes Market
The global CRISPR and CRISPR-Associated (Cas) Genes market was valued at US$ 1431.1 in 2020 and will reach US$ 7743.9 million by the end of 2027, growing at a CAGR of 32.5% during 2022-2027.
Global CRISPR and CRISPR-Associated (Cas) Genes Scope and Market Size
The global CRISPR and CRISPR-Associated (Cas) Genes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR and CRISPR-Associated (Cas) Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
The CRISPR and CRISPR-Associated (Cas) Genes market is analysed and market size information is provided by regions (countries). Segment by Application, the CRISPR and CRISPR-Associated (Cas) Genes market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
1 CRISPR and CRISPR-Associated (Cas) Genes Market Overview
1.1 CRISPR and CRISPR-Associated (Cas) Genes Product Scope
1.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016 & 2021 & 2027)
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts (2016-2027)
1.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size in Value Growth Rate (2016-2027)
1.4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price Trends (2016-2027)
2 CRISPR and CRISPR-Associated (Cas) Genes Estimates and Forecasts by Region
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2016-2021)
2.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2016-2021)
2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.3 China CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.4 Japan CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.5 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
2.4.6 India CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2016-2027)
3 Global CRISPR and CRISPR-Associated (Cas) Genes Competition Landscape by Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Sales (2016-2021)
3.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2016-2021)
3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2020)
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Average Price by Company (2016-2021)
3.5 Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Review by Type (2016-2021)
4.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
4.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2021)
4.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type (2016-2021)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Type (2022-2027)
4.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Type (2022-2027)
4.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Type (2022-2027)
5 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Review by Application (2016-2021)
5.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
5.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2016-2021)
5.1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Application (2016-2021)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Application (2022-2027)
5.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Application (2022-2027)
5.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Application (2022-2027)
6 North America CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
6.1.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
6.1.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2016-2021)
6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2022-2027)
7 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
7.1.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
7.1.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
8.1 China CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
8.1.1 China CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
8.1.2 China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
8.2 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
8.2.1 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
8.2.2 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
8.3 China CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
9.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
9.1.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
9.1.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
9.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
9.2.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
9.2.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
9.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
10.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
10.1.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
10.1.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
10.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
10.2.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
11.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales by Company
11.1.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2016-2021)
11.1.2 India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021)
11.2 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type
11.2.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2016-2021)
11.2.2 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Type (2022-2027)
11.3 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application
11.3.1 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2016-2021)
11.3.2 India CRISPR and CRISPR-Associated (Cas) Genes Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in CRISPR and CRISPR-Associated (Cas) Genes Business
12.1 Caribou Biosciences
12.1.1 Caribou Biosciences Corporation Information
12.1.2 Caribou Biosciences Business Overview
12.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.1.5 Caribou Biosciences Recent Development
12.2 Addgene
12.2.1 Addgene Corporation Information
12.2.2 Addgene Business Overview
12.2.3 Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Addgene CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.2.5 Addgene Recent Development
12.3 CRISPR THERAPEUTICS
12.3.1 CRISPR THERAPEUTICS Corporation Information
12.3.2 CRISPR THERAPEUTICS Business Overview
12.3.3 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.3.5 CRISPR THERAPEUTICS Recent Development
12.4 Merck KGaA
12.4.1 Merck KGaA Corporation Information
12.4.2 Merck KGaA Business Overview
12.4.3 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.4.5 Merck KGaA Recent Development
12.5 Mirus Bio LLC
12.5.1 Mirus Bio LLC Corporation Information
12.5.2 Mirus Bio LLC Business Overview
12.5.3 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.5.5 Mirus Bio LLC Recent Development
12.6 Editas Medicine
12.6.1 Editas Medicine Corporation Information
12.6.2 Editas Medicine Business Overview
12.6.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.6.5 Editas Medicine Recent Development
12.7 Takara Bio USA
12.7.1 Takara Bio USA Corporation Information
12.7.2 Takara Bio USA Business Overview
12.7.3 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.7.5 Takara Bio USA Recent Development
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Corporation Information
12.8.2 Thermo Fisher Scientific Business Overview
12.8.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.8.5 Thermo Fisher Scientific Recent Development
12.9 Horizon Discovery Group
12.9.1 Horizon Discovery Group Corporation Information
12.9.2 Horizon Discovery Group Business Overview
12.9.3 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.9.5 Horizon Discovery Group Recent Development
12.10 Intellia Therapeutics
12.10.1 Intellia Therapeutics Corporation Information
12.10.2 Intellia Therapeutics Business Overview
12.10.3 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.10.5 Intellia Therapeutics Recent Development
12.11 GE Healthcare Dharmacon
12.11.1 GE Healthcare Dharmacon Corporation Information
12.11.2 GE Healthcare Dharmacon Business Overview
12.11.3 GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Products Offered
12.11.5 GE Healthcare Dharmacon Recent Development
13 CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Cost Analysis
13.1 CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of CRISPR and CRISPR-Associated (Cas) Genes
13.4 CRISPR and CRISPR-Associated (Cas) Genes Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 CRISPR and CRISPR-Associated (Cas) Genes Distributors List
14.3 CRISPR and CRISPR-Associated (Cas) Genes Customers
15 Market Dynamics
15.1 CRISPR and CRISPR-Associated (Cas) Genes Market Trends
15.2 CRISPR and CRISPR-Associated (Cas) Genes Drivers
15.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
15.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Region (2016-2021)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2016-2021)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Region (2016-2021)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share Forecast by Region (2022-2027)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share Forecast by Region (2022-2027)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) of Key Companies (2016-2021)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Company (2016-2021)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) by Company (2016-2021)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Company (2016-2021)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2020)
Table 17. Global CRISPR and CRISPR-Associated (Cas) Genes Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Sites and Area Served
Table 19. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2016-2021)
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Type (2016-2021)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Type (2016-2021)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Type (2022-2027)
Table 26. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Type (2022-2027)
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Type (2022-2027)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2016-2021)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Application (2016-2021)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Application (2016-2021)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Application (2022-2027)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Application (2022-2027)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2022-2027)
Table 37. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Application (2022-2027)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 39. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 40. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 42. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 43. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 44. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 45. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 46. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 47. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 48. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 49. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 50. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 51. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 52. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 54. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 55. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 56. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 57. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 58. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 59. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 60. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 61. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 62. China CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 63. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 64. China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 65. China CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 66. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 67. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 68. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 69. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 70. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 71. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 72. China CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 73. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 74. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 75. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 76. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 78. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 79. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 80. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 81. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 82. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 83. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 84. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 85. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 98. India CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Company (2016-2021)
Table 99. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2016-2021)
Table 100. India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2016-2021) & (US$ Million)
Table 101. India CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2016-2021)
Table 102. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 103. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 104. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2022-2027) & (K Units)
Table 105. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2022-2027)
Table 106. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 107. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 108. India CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2022-2027) & (K Units)
Table 109. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2022-2027)
Table 110. Caribou Biosciences Corporation Information
Table 111. Caribou Biosciences Description and Business Overview
Table 112. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 114. Caribou Biosciences Recent Development
Table 115. Addgene Corporation Information
Table 116. Addgene Description and Business Overview
Table 117. Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Addgene CRISPR and CRISPR-Associated (Cas) Genes Product
Table 119. Addgene Recent Development
Table 120. CRISPR THERAPEUTICS Corporation Information
Table 121. CRISPR THERAPEUTICS Description and Business Overview
Table 122. CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Product
Table 124. CRISPR THERAPEUTICS Recent Development
Table 125. Merck KGaA Corporation Information
Table 126. Merck KGaA Description and Business Overview
Table 127. Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Product
Table 129. Merck KGaA Recent Development
Table 130. Mirus Bio LLC Corporation Information
Table 131. Mirus Bio LLC Description and Business Overview
Table 132. Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Product
Table 134. Mirus Bio LLC Recent Development
Table 135. Editas Medicine Corporation Information
Table 136. Editas Medicine Description and Business Overview
Table 137. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 139. Editas Medicine Recent Development
Table 140. Takara Bio USA Corporation Information
Table 141. Takara Bio USA Description and Business Overview
Table 142. Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Product
Table 144. Takara Bio USA Recent Development
Table 145. Thermo Fisher Scientific Corporation Information
Table 146. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Thermo Fisher Scientific Description and Business Overview
Table 148. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 149. Thermo Fisher Scientific Recent Development
Table 150. Horizon Discovery Group Corporation Information
Table 151. Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Horizon Discovery Group Description and Business Overview
Table 153. Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Product
Table 154. Horizon Discovery Group Recent Development
Table 155. Intellia Therapeutics Corporation Information
Table 156. Intellia Therapeutics Description and Business Overview
Table 157. Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 159. Intellia Therapeutics Recent Development
Table 160. GE Healthcare Dharmacon Corporation Information
Table 161. GE Healthcare Dharmacon Description and Business Overview
Table 162. GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Product
Table 164. GE Healthcare Dharmacon Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. CRISPR and CRISPR-Associated (Cas) Genes Distributors List
Table 168. CRISPR and CRISPR-Associated (Cas) Genes Customers List
Table 169. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 170. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 171. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 172. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Product Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2021 & 2027
Figure 6. Biotechnology Companies Examples
Figure 7. Pharmaceutical Companies Examples
Figure 8. Academic Institutes Examples
Figure 9. Research and Development Institutes Examples
Figure 10. Global CRISPR and CRISPR-Associated (Cas) Genes Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global CRISPR and CRISPR-Associated (Cas) Genes Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China CRISPR and CRISPR-Associated (Cas) Genes Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India CRISPR and CRISPR-Associated (Cas) Genes Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Revenue in CRISPR and CRISPR-Associated (Cas) Genes: 2016 & 2020
Figure 29. CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Type (2016-2021)
Figure 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2016-2021)
Figure 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 35. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 36. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 37. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 38. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 39. China CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 40. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 41. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 42. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 43. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 44. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 45. India CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of CRISPR and CRISPR-Associated (Cas) Genes
Figure 48. Manufacturing Process Analysis of CRISPR and CRISPR-Associated (Cas) Genes
Figure 49. CRISPR and CRISPR-Associated (Cas) Genes Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界のCRISPR＆Cas遺伝子市場規模・現状・予測（2021年-2027年） CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to d…- 世界のCRISPRベース治療法市場規模・現状・予測（2021年-2027年） CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases. Market Analysis and Insights: Global CRISPR-Based Therapeutics Market The global CRISPR-Based Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in …
- 世界のCRISPRゲノム編集市場規模・現状・予測（2021年-2027年） CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR. Market Analysis and Insights: Global CRISPR Genome Editing Market The global CRISPR Genome Editing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of X…
- 世界の遺伝子編集ツール市場規模・現状・予測（2021年-2027年） Gene editing (or genome editing) is the insertion, deletion or replacement of DNA at a specific site in the genome of an organism or cell. It is usually achieved in the lab using engineered nucleases also known as molecular scissors. Market Analysis and Insights: Global Gene Editing Tools Market The…
- 世界の遺伝子編集技術市場規模・現状・予測（2021年-2027年） Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism. Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments. Gene editing relies on genetical…